Clinal Trial With Oral and Local drugs in management of Tinea Corporis
Phase 2
- Conditions
- Health Condition 1: B354- Tinea corporis
- Registration Number
- CTRI/2024/05/066758
- Lead Sponsor
- Government Tibbi College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients those who have subjective and objective signs and symptoms or diagnosed case of Tinea corporis.
2.Patients with positive mycology test(KOH positive).
3.Patients of either gender.
4.Patients in the age group of 18-50 years.
5.Patients who have agreed to participate and sign the informed consent form and follow the protocol.
Exclusion Criteria
1.Co-morbid conditions of the participant like DM, HTN, CAD, CKD and other autoimmune diseases.
2.Participants suffering from concomitant diseases like Psoriasis and eczema.
3.Pregnant or lactating women.
4.Known cases of immuno-compromised states like AIDS, Malignancies and on immuno-suppressive drugs
5.Participants fail to attend treatment schedule regularly.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Sign and symptom score(TSSS)Timepoint: 1st week to 6 weeks
- Secondary Outcome Measures
Name Time Method Conversion to Negative mycology testTimepoint: At 6 Week